These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21628141)

  • 61. Practical aspects of insulin pen devices.
    Pearson TL
    J Diabetes Sci Technol; 2010 May; 4(3):522-31. PubMed ID: 20513316
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Endless Pursuit: Evolution of Insulin Administration.
    Sun C; Yu J; Lin K; Han R; Hu L
    Curr Pharm Biotechnol; 2018; 19(9):742-753. PubMed ID: 30227816
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Half-Unit Insulin Pens: Disease Management in Patients With Diabetes Who Are Sensitive to Insulin.
    Klonoff DC; Nayberg I; Stauder U; Oualali H; Domenger C
    J Diabetes Sci Technol; 2017 May; 11(3):623-630. PubMed ID: 27898389
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of insulin in diabetes: a century of treatment.
    Shahani S; Shahani L
    Hong Kong Med J; 2015 Dec; 21(6):553-9. PubMed ID: 26554270
    [TBL] [Abstract][Full Text] [Related]  

  • 65. FlexTouch® for the delivery of insulin: technical attributes and perception among patients and healthcare professionals.
    Bailey T; Campos C
    Expert Rev Med Devices; 2012 May; 9(3):209-17. PubMed ID: 22471783
    [TBL] [Abstract][Full Text] [Related]  

  • 66. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2010 Feb; (166):29-40. PubMed ID: 20377662
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Administration of Biosimilar Insulin Analogs: Role of Devices.
    Heinemann L; Fritz I; Khatami H; Edelman SV
    Diabetes Technol Ther; 2017 Feb; 19(2):79-84. PubMed ID: 28118050
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pen Devices for Insulin Self-Administration Compared With Needle and Vial: Systematic Review of the Literature and Meta-Analysis.
    Lasalvia P; Barahona-Correa JE; Romero-Alvernia DM; Gil-Tamayo S; Castañeda-Cardona C; Bayona JG; Triana JJ; Laserna AF; Mejía-Torres M; Restrepo-Jimenez P; Jimenez-Zapata J; Rosselli D
    J Diabetes Sci Technol; 2016 Jul; 10(4):959-66. PubMed ID: 26920639
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Novel Concentrated Insulin Delivery Devices: Developments for Safe and Simple Dose Conversions.
    Johnson JL; Downes JM; Obi CK; Asante NB
    J Diabetes Sci Technol; 2017 May; 11(3):618-622. PubMed ID: 27898390
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of insulin delivery systems.
    Siddiqui NI; Rahman S; Nessa A
    Mymensingh Med J; 2008 Jan; 17(1):102-10. PubMed ID: 18285745
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Costs of medication nonadherence in patients with diabetes mellitus: a systematic review and critical analysis of the literature.
    Salas M; Hughes D; Zuluaga A; Vardeva K; Lebmeier M
    Value Health; 2009 Sep; 12(6):915-22. PubMed ID: 19402848
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Adherence and Outcomes Benefits of Using a Connected, Reusable Auto-Injector for Self-Injecting Biologics: A Narrative Review.
    Antalfy A; Berman K; Everitt C; Alten R; Latymer M; Godfrey CM
    Adv Ther; 2023 Nov; 40(11):4758-4776. PubMed ID: 37733212
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Update on insulin treatment for dogs and cats: insulin dosing pens and more.
    Thompson A; Lathan P; Fleeman L
    Vet Med (Auckl); 2015; 6():129-142. PubMed ID: 30101100
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Insulin pen injection devices for management of patients with type 2 diabetes: considerations based on an endocrinologist's practical experience in the United States.
    Thurman JE
    Endocr Pract; 2007 Oct; 13(6):672-8. PubMed ID: 17954427
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Research regarding proper use of insulin in diabetes patients].
    Asakura T
    Yakugaku Zasshi; 2001 Sep; 121(9):653-61. PubMed ID: 11558149
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Digital Diabetes Management: A Literature Review of Smart Insulin Pens.
    Heinemann L; Schnell O; Gehr B; Schloot NC; Görgens SW; Görgen C
    J Diabetes Sci Technol; 2022 May; 16(3):587-595. PubMed ID: 33430644
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Advantages and disadvantages of connected insulin pens in diabetes management.
    Lingen K; Pikounis T; Bellini N; Isaacs D
    Endocr Connect; 2023 Nov; 12(11):. PubMed ID: 37610002
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Changes in the insulin application sites and in the syringes reutilized by diabetic patients].
    Castro Adel R; Graziano KU; Grossi SA
    Rev Gaucha Enferm; 2006 Mar; 27(1):27-34. PubMed ID: 16894870
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Insulin Therapy for the Management of Diabetes Mellitus: A Narrative Review of Innovative Treatment Strategies.
    Nkonge KM; Nkonge DK; Nkonge TN
    Diabetes Ther; 2023 Nov; 14(11):1801-1831. PubMed ID: 37736787
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Insulin preparation for clinical use].
    Namai K; Kanazawa Y
    Nihon Rinsho; 1997 Nov; 55 Suppl():225-32. PubMed ID: 9434472
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.